The many flavors of tumor-associated B cells

OncoImmunology

Volumn 2, Issue 8, 2013, Pages

  Marits, Per ^a   Ali Zirakzadeh, A ^a   Sherif, Amir ^b   Winqvist, Ola ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adoptive immunotherapy; Antigen presenting cell; B cell subtypes; Clonal expansion; Tumor draining lymph nodes

Indexed keywords

CD19 ANTIGEN; CD86 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CATALYST; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; COMMON VARIABLE IMMUNODEFICIENCY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PRIMARY TUMOR; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84885738360     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.25237     Document Type: Article

References (9)

1. Nielsen JS, Nelson BH. Tumor-infiltrating B cells and T cells: Working together to promote patient survival. Oncoimmunology 2012; 1:1623-5; PMID:23264915; http://dx.doi.org/10.4161/onci.21650
2. Maletzki C, Jahnke A, Ostwald C, Klar E, Prall F, Linnebacher M. Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG. PLoS One 2012; 7:e32639; PMID:22393427; http://dx.doi. org/10.1371/journal.pone.0032639
3. Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008; 74:261-71; PMID:18561200; http://dx.doi.org/10.1002/cyto.b.20432
4. Kuzmina Z, Greinix HT, Weigl R, Körmöczi U, Rottal A, Frantal S, et al. Significant differences in B-cell subpopulations characterize patients with chronic graftversus- host disease-associated dysgammaglobulinemia. Blood 2011; 117:2265-74; PMID:21063025; http:// dx.doi.org/10.1182/blood-2010-07-295766
5. Zirakzadeh AA, Marits P, Sherif A, Winqvist O, Multiplex B. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies. J Immunol 2013; 190:5847-55; PMID:23630345; http://dx.doi.org/10.4049/jimmunol.1203279
6. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24:467-96; PMID:16551256; http://dx.doi. org/10.1146/annurev.immunol.24.021605.090517
7. Ron Y, Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol 1987; 138:2848-56; PMID:2952725
8. Karlsson M, Marits P, Dahl K, Dagöö T, Enerbäck S, Thörn M, et al. Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer. Ann Surg Oncol 2010; 17:1747-57; PMID:20119674; http://dx.doi.org/10.1245/s10434-010-0920-8
9. Sherif A, Hasan MN, Marits P, Karlsson M, Winqvist O, Thörn M. Feasibility of T-cell-based adoptive immunotherapy in the first 12 patients with advanced urothelial urinary bladder cancer. Preliminary data on a new immunologic treatment based on the sentinel node concept. Eur Urol 2010; 58:105-11; PMID:19766386; http://dx.doi.org/10.1016/j.eururo.2009.09.026